Cabio Biotech (Wuhan) Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: CNE100005X31
CNY
22.89
0.04 (0.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
149.41
154.92
167.02
124.63
142.48
116.02
116.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
149.41
154.92
167.02
124.63
142.48
116.02
116.55
Raw Material Cost
76.47
81.96
82.62
84.56
82.86
71.08
66.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.63
0.16
0.08
0.09
0.11
0.12
0.11
Selling and Distribution Expenses
-0.72
18.02
26.37
16.32
8.34
12.79
8.31
Other Expenses
0.89
0.81
1.26
1.13
1.03
0.93
0.95
Total Expenditure (Excl Depreciation)
85.27
108.22
121.62
112.31
101.65
93.33
83.94
Operating Profit (PBDIT) excl Other Income
64.1
46.7
45.4
12.3
40.8
22.7
32.599999999999994
Other Income
6.44
10.68
9.35
3.64
11.49
6.69
7.54
Operating Profit (PBDIT)
86.05
71.65
59.46
31.91
63.18
43.15
50.80
Interest
0.63
0.16
0.08
0.09
0.11
0.12
0.11
Exceptional Items
0.09
-4.59
0.02
-0.47
1.36
-0.64
-2.17
Gross Profit (PBDT)
72.94
72.96
84.40
40.07
59.62
44.94
50.50
Depreciation
15.16
15.16
14.92
14.92
14.32
14.32
12.72
Profit Before Tax
70.35
51.74
44.47
16.42
50.11
28.06
35.80
Tax
9.44
7.35
6.57
1.41
7.33
4.39
5.18
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
62.96
45.00
40.32
16.00
43.58
24.31
30.96
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
62.96
45.00
40.32
16.00
43.58
24.31
30.96
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.97
-0.60
-1.35
-1.16
-0.93
-0.64
-1.72
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
61.99
44.39
38.97
14.84
42.65
23.67
29.24
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,626.01
1,596.73
1,556.09
1,526.59
1,510.57
1,500.66
1,476.35
Earnings per share (EPS)
0.38
0.27
0.24
0.1
0.26
0.14
0.18
Diluted Earnings per share
0.38
0.27
0.24
0.1
0.26
0.14
0.18
Operating Profit Margin (Excl OI)
43.13%
29.57%
21.07%
10.71%
26.23%
19.07%
26.2%
Gross Profit Margin
57.23%
43.18%
35.56%
25.15%
45.22%
36.53%
41.63%
PAT Margin
42.14%
29.04%
24.14%
12.84%
30.58%
20.95%
26.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is -3.55% vs -7.25% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 39.64% vs 13.85% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 30.49% vs 21.76% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 200.00% vs 100.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Cabio Biotech (Wuhan) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
149.41
0
149.41
Other Operating Income
0.00
0.00
0.00
Total Operating income
149.41
0
149.41
Raw Material Cost
76.47
0
76.47
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.63
0
0.63
Selling and Distribution Expenses
-0.72
0
-0.72
Other Expenses
0.89
0.00
0.89
Total Expenditure (Excl Depreciation)
85.27
0
85.27
Operating Profit (PBDIT) excl Other Income
64.14
0.00
64.14
Other Income
6.44
0
6.44
Operating Profit (PBDIT)
86.05
0
86.05
Interest
0.63
0
0.63
Exceptional Items
0.09
0
0.09
Gross Profit (PBDT)
72.94
0
72.94
Depreciation
15.16
0
15.16
Profit Before Tax
70.35
0
70.35
Tax
9.44
0
9.44
Provisions and contingencies
0
0
0.00
Profit After Tax
62.96
0
62.96
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
62.96
0
62.96
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.97
0
-0.97
Other related items
0.00
0.00
0.00
Consolidated Net Profit
61.99
0
61.99
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,626.01
0
1,626.01
Earnings per share (EPS)
0.38
0
0.38
Diluted Earnings per share
0.38
0
0.38
Operating Profit Margin (Excl OI)
43.13%
0%
0.00
43.13%
Gross Profit Margin
57.23%
0%
0.00
57.23%
PAT Margin
42.14%
0%
0.00
42.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 14.94 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -3.55% vs -7.25% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 4.84% vs 29.55% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.20 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 39.64% vs 13.85% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 45.54% vs 121.88% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.96 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 30.49% vs 21.76% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 53.97% vs 117.23% in Jun 2024

Quarterly - Interest
Interest 0.06 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 200.00% vs 100.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 500.00% vs 0.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 43.13%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024